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ABSTRACT
SHP2 is a widely expressed protein tyrosine phosphatase required for signal transduction from
multiple cell surface receptors. Gain and loss of function SHP2 mutations in humans are known
to cause Noonan and LEOPARD syndromes, respectively, that are characterized by numerous
pathological conditions including male infertility. Using conditional gene targeting in the mouse,
we found that SHP2 is required for maintaining spermatogonial stem cells (SSCs) and the pro-
duction of germ cells required for male fertility. After deleting SHP2, spermatogenesis was
halted at the initial step during which transit-amplifying undifferentiated spermatogonia are
produced from SSCs. In the absence of SHP2, proliferation of SSCs and undifferentiated sperma-
togonia was inhibited, thus germ cells cannot be replenished and SSCs cannot undergo renewal.
However, germ cells beyond the undifferentiated spermatogonia stage of development at the
time of SHP2 knockout were able to complete their maturation to become sperm. In cultures
of SSCs and their progeny, inhibition of SHP2 activity reduced growth factor-mediated intracellu-
lar signaling that regulates SSC proliferation and cell fate. Inhibition of SHP2 also decreased the
number of SSCs present in culture and caused SSCs to detach from supporting cells. Injection of
mice with an SHP2 inhibitor blocked the production of germ cells from SSCs. Together, our stud-
ies show that SHP2 is essential for SSCs to maintain fertility and indicates that the pathogenesis
of infertility in humans with SHP2 mutations is due to compromised SSC functions that block
spermatogenesis. STEM CELLS 2014;32:741–753
INTRODUCTION
Male fertility is maintained by the highly pro-
ductive process of spermatogenesis that in men
generates more than 100 million sperm every
day. In mice, spermatogenesis initiates 3 days
after birth with gonocyte germ cell precursors
giving rise to two types of cells: spermatogonial
stem cells (SSCs) or differentiated spermatogo-
nia [1, 2]. SSCs are rare in adults (0.03% of all
adult mouse germ cells) and are present as sin-
gle cells that continuously self-renew and pro-
duce undifferentiated spermatogonia that
function as transit-amplifying progenitor cells
[3]. Undifferentiated spermatogonia transition
to become differentiated spermatogonia that
undergo additional mitotic divisions resulting in
cells committed to meiosis and sperm develop-
ment. The only exception to this well-ordered
process is the ﬁrst wave of spermatogenesis
that consists of a shortened developmental pro-
gram in which a population of gonocytes pro-
duce differentiated type A2 spermatogonia 3–4
days after birth without passing through the
SSC and undifferentiated spermatogonia stages
of development [1, 4]. After completion of the
ﬁrst wave of spermatogenesis, all germ cells
are replenished from SSCs.
Growth factors including glial cell-derived
neurotrophic factor (GDNF) and basic ﬁbro-
blast growth factor (bFGF) produced by Sertoli
cells support the renewal and proliferation of
SSCs [5–7], but the intracellular factors and
signaling pathways that regulate SSC fate deci-
sions are not well-characterized. A candidate
mediator of GDNF and bFGF signaling in SSCs
is the widely expressed SHP2 protein tyrosine
phosphatase encoded by the Ptpn11 gene.
SHP2 mediates intracellular signaling after
stimulation with GDNF and bFGF in nontesticu-
lar cell types [8, 9]. Upon growth factor or
cytokine stimulation, SHP2 is recruited to
growth factor receptors [10]. SHP2 is then
capable of regulating signaling cascades that
are known to decide SSC fate. In other cell
types, SHP2 stimulates the PI3K/AKT and Ras-
MAPK (ERK) pathways but SHP2 can activate
or inhibit the JAK/STAT pathway [11–13].
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TISSUE-SPECIFIC STEM CELLS
Mutations that constitutively activate or inhibit SHP2
activity result in human pathologies. Missense mutations in
Ptpn11 result in LEOPARD syndrome that is characterized by
heart, lung, ocular, growth, and genitalia abnormalities [14].
In mice, disruption of the Ptpn11 gene results in embryonic
lethality [15]. Constitutive activation of SHP2 can result in
juvenile leukemias [16, 17] and the juvenile development dis-
order Noonan Syndrome that includes facial dysmorphia, con-
genital heart defects, short stature, and male infertility [17].
Noonan syndrome is also the most common human autoso-
mal dominant genetic disease that results in infertility [18].
We found that expression of a constitutively active SHP2
mutant in cultured rat Sertoli cells causes the mislocalization
of proteins required to maintain the blood-testis barrier (BTB)
[19]. Thus, SHP2 is a potential regulator of essential processes
in both Sertoli cells and SSCs that are required for male
fertility.
To date, the consequences of eliminating SHP2 activity in
the testis have not been investigated. In this study, we used
two complimentary SHP2 knockout mouse models to deter-
mine that SHP2 is required to maintain spermatogenesis and
male fertility. In the absence of SHP2, spermatogenesis is
blocked at the initial step due to defects in the proliferation
and survival of SSCs such that undifferentiated spermatogonia
cannot be produced. Also, global knockout of SHP2 in adult
mice causes defects in the orientation and migration of devel-
oping spermatids. In addition, we ﬁnd that inhibition of SHP2
activity causes detachment of SSCs from supporting cells,
decreases the number of SSCs present in culture, and disrupts
intracellular signaling pathways required for the self-renewal
and proliferation of SSCs.
MATERIALS AND METHODS
Transgenic Mice
Animals used in these studies were maintained and eutha-
nized according to the principles and procedures described in
the NIH Guide for the Care and Use of Laboratory Animals.
These studies were approved by the University of Pittsburgh
Institutional Animal Care and Use Committee. Previously
described Ptpn11ﬂ/ﬂ mice and ubiquitin-promoter-driven ert2-
cre transgenic mice [20, 21] were mated to generate Ptpn11ﬂ/
ﬂ ert2-cre mice. To create Ptpn11D/D mice, adult (6–8 weeks
old) or pubertal (8 days old) Ptpn11ﬂ/ﬂ ert2-cre mice were
injected twice with tamoxifen (200 mg/g b.wt. in corn oil) on
2 consecutive days as described [22] and sacriﬁced 6–63 days
later. Wild-type littermates were similarly injected with tamox-
ifen. To generate GCSHP2KO mice, Ptpn11ﬂ/ﬂ mice were mated
with Vasa-cre (Ddx4-cre) mice [23] and resulting Ptpn11wt/D
Vasa-cre1/2 males were mated to Ptpn11ﬂ/ﬂ Vasa-cre2/2
females to obtain Ptpn11D/D Vasa-cre1/2 mice that lack
Ptpn11 exon 4 speciﬁcally in germ cells.
Genotyping
Generation and genotypic identiﬁcation of Ptpn11ﬂ/ﬂ and
ert2-cre transgenic mice are described elsewhere [20, 21]. The
primer pairs used in PCR assays to determine the presence of
ﬂoxed Ptpn11, recombined Ptpn11, ert2-cre, and Vasa-Cre are
listed in Supporting Information Table S1.
Reagents and Antibodies
FGF, GDNF, NSC-87877, and tamoxifen were obtained from BD
Biosciences (San Jose, CA, www.bdbiosciences.com), PeproTech
(Rocky Hill, NJ, www.preprotech.com), Tocris Bioscience (Bristol,
U.K.), and Sigma (St. Louis, MO, www.sigmaaldrich.com), respec-
tively. Antisera sources, applications, and the dilutions used are
summarized in Supporting Information Table S2.
Preparation of Whole Cell Extracts and Immunoblot
Analysis
To prepare testis whole cell lysates (WCE), testes were decapsu-
lated and homogenized in enhanced lysis buffer (250 mM NaCl,
0.1% Nonidet P40, 50 mM Hepes, pH 7.0, 5 mM EDTA, and 0.5
mM dithiothreitol) with a protease inhibitor cocktail, rocked for
15 minutes at 4C, and then pelleted (12,000g 15 minutes) to
remove cell debris. WCE were fractionated by 10% SDS-PAGE and
transferred to Immobilon-P, PVDF membranes (Millipore Corp.,
Bedford, MA, www.millipore.com), blocked with 5% non-fat dry
milk in Tris-buffered saline (25 mM TRIS-HCl, pH 7.4, 0.15 M NaCl,
containing 0.1% Tween 20), and incubated overnight at 4C with
the appropriate primary antibody. The blots were washed, incu-
bated with species-speciﬁc secondary antibodies, and visualized
with chemiluminescent HRP substrate (Millipore Corp.).
Germ Line Stem Cultures
Germ line stem (GS) cell cultures were isolated from 6-day-
old DBA/2 mice as described previously [24]. Brieﬂy, a testicu-
lar cell suspension was isolated by enzymatic digestion with
DNase and trypsin and ﬁltered through a 40 mm mesh to
remove cell clumps. Germ cells were then enriched through a
30% percoll gradient and subjected to magnetic activated cell
sorting to select Thy11 cells to enrich for SSCs. The cells
were washed in mouse SSC serum-free medium (mSFM) and
plated onto SIM mouse embryo-derived thioguanine- and
ouabain-resistant (STO) ﬁbroblast cell line feeder cells in
mSFM supplemented with 20 ng/ml recombinant human
GDNF and 20 ng/ml human recombinant basic FGF (bFGF). GS
cultures were subcultured at 1:2–1:3 ratios onto fresh STO
feeders every 7 days and were used for experiments between
1 and 3 months after establishment. GS cultures were starved
of bFGF and GDNF overnight and incubated in the absence
and presence of NSC-87877 for 6–8 hours. SSCs were
detached from feeders and bFGF or GDNF was added for 10
minutes. Detached SSCs were then pelleted (600g, 7 minutes)
and lysed in Laemmli sample buffer.
Immunocytochemistry and Immunofluorescence
Immunostaining of testis tissue was performed on parafﬁn-
embedded sections (5 mm) from paraformaldehyde (4%, o/n) or
Bouin’s ﬁxed adult rat testis as previously described [19]. Testis
sections were deparafﬁnized in xylene and rehydrated. The sec-
tions were subjected to antigen retrieval in citrate buffer (10 mm
citrate, pH 6.0, containing 0.1% Tween 20) at 95C for 30 minutes
and then at room temperature for 30 minutes. The sections were
washed two times for 5 minutes in phosphate buffered saline
and blocked with goat, donkey, or horse serum. The testis sec-
tions were then incubated 12–24 hours with nonimmune serum
or antiserum as detailed in Supporting Information Table S2. For
colorimetric assays, anti-rabbit or anti-mouse biotinylated sec-
ondary antibody (Vectastain Elite ABC Kit, Vector Laboratories,
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Burlingame, CA, www.vectorlabs.com) was added, and bound
antibodies were detected using DAB staining colorimetric rea-
gent and counterstained with hematoxylin. For immunoﬂuores-
cence studies, Cy3 and ALexa488-conjugated secondary antisera
were added, nuclei were stained with 4060-diamidino-2-phenylin-
dole, and immunostaining was detected using a Nikon Provis II
ﬂuorescence microscope or confocal microscope. A charge-
coupled video camera system was used to capture images. All
ﬁles were digitally processed with Photoshop (Adobe Systems,
Inc., San Jose, CA, www.adobe.com).
TUNEL Assay, Cell Counting, and LIVE/DEAD Staining
Paraformaldehyde-ﬁxed testis sections were evaluated using a
TUNEL assay kit (Roche). All immunostained cells and tubules from
an entire testis section were counted and the number of stained
cells per tubule was determined. GS cell viability was determined
using the LIVE/DEAD viability assay kit for mammalian cells (Life
Technologies, Carlsbad, CA, www.lifetechnologies.com).
Statistical Analysis
Immunoreactive signals from Western blot ﬁlms were scanned
with an Epson 1600 Expressions scanner using Epson Scan
software. Results were analyzed by ANOVA with Newman-
Keuls PLSD or unpaired t test at a 5% signiﬁcance level using
Prism 4.3 (GraphPad Software, LA Jolla, CA,
www.graphpad.com).
RESULTS
The Induced Deletion of SHP2 in Adult Mice Blocks
Spermatogenesis
To deﬁne the function of SHP2 in spermatogenesis, we ﬁrst
eliminated SHP2 expression in adult Ptpn11ﬂ/ﬂert2-cre mice.
These mice express ﬂoxed alleles of Ptpn11 and a tamoxifen-
inducible Cre recombinase driven by a ubiquitin promoter.
Administration of tamoxifen to these mice causes the excision
of exon 4 at the Ptpn11 locus, creating a null mutant allele
for SHP2 [21, 22]. Adult ([mt]60 days old) Ptpn11f//ﬂert2-cre
and Ptpn11ﬂ/ﬂ (control) mice were treated with tamoxifen to
ablate SHP2 expression and sacriﬁced 29, 43, and 63 days
later. PCR analysis of genomic DNA isolated from the testis of
the tamoxifen-treated Ptpn11ﬂ/ﬂert2-cre mice (hereafter
Ptpn11D/D mice) and control mice conﬁrmed the
Cre-mediated excision of Ptpn11 exon 4 in the testis (Fig. 1A).
Immunoblot analysis showed that the protein levels of SHP2
Figure 1. Induced global knockout of SHP2 blocks spermatogenesis. (A): PCR analysis of testis genomic DNA using primers ﬂanking exon 4
of the gene encoding SHP2. The ampliﬁed products are shown for reactions using genomic DNA isolated from the testes of WT mice, ﬂoxed
Ptpn11 and Ptpn11D/D mice 29, 43, and 63 days after tamoxifen treatment. (B): Western immunoblot analysis of SHP2 and actin protein
expression in whole cell extracts from testes isolated from control and Ptpn11D/D mice 29 and 43 days after tamoxifen treatment. (C–F): Tes-
tis tissue sections from control mice (C), and Ptpn11D/D mice 29 (D), 43 (E), and 63 (F) days after tamoxifen treatment were probed with
antisera against VASA (brown stain). Nuclei are stained blue with hematoxylin. Seminiferous tubule cross-sections showing disrupted sperma-
togenesis as measured by two or fewer layers of germ cells are marked with an asterisk (*). (G–J): Testis tissue sections from control mice
(G) and Ptpn11D/D mice 29 (H), 43 (I), and 63 (J) days after tamoxifen treatment were stained with periodic acid Schiffs-hematoxylin
(PAS-H). Sertoli cell nuclei are marked with black arrowheads. Spermatogonia and preleptotene spermatocytes on the basement membrane
are marked with green arrows. Vacuoles in regions lacking germ cells are noted with red arrows. Mislocalized elongated spermatids are
marked with orange arrows. C–F: Bar5 100 mm, G–J: Bar5 20 mm. Abbreviation: WT, wild type.
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in animals treated with tamoxifen were decreased (Fig. 1B).
The PCR and immunoblot analyses also indicated that the
excision of exon 4 did not occur in all cells and that some
SHP2 protein expression was retained in the Ptpn11D/D mouse
testis.
Testes weights of Ptpn11D/D mice 29 and 43 days after
tamoxifen treatment were reduced by 36% and 52%,
respectively. In contrast to the intact spermatogenesis
observed in controls (Fig. 1C), spermatogenesis was dis-
rupted in 33% of tubule cross-sections from Ptpn11D/D
mice 29 days after tamoxifen treatment as deﬁned by the
presence of two or fewer layers of germ cells stained with
Vasa antiserum that identiﬁes all germ cells (Fig. 1D). After
43 and 63 days, 43% and 27% of tubule cross-sections
showed disrupted spermatogenesis, respectively (Fig. 1E,
1F). The mosaic nature of the gene knockout is commonly
seen in tamoxifen-induced knockout mouse models [25]
and varying efﬁciencies of gene ablation using the ert2-cre
to knockout SHP2 have been shown for various tissues [22].
The presence of tubules with intact spermatogenesis also
indicates that the observed disrupted spermatogenesis did
not result from nonspeciﬁc actions of tamoxifen, damage to
Leydig cells, or some insult to the hypothalamic-pituitary-
testis endocrine axis.
SHP2 Ablation Blocks Spermatogenesis Prior
to Spermatogonia Development
The disruption of spermatogenesis in Ptpn11D/D mice led us
to examine the germ cell complement of Ptpn11D/D testes in
greater detail. In cross-sections from control mice, spermato-
gonia, preleptotene spermatocytes, and Sertoli cell nuclei are
present along the basement membrane (Fig. 1G). In contrast,
cross-sections from disrupted tubules in Ptpn11D/D mice 29
days after tamoxifen treatment had only Sertoli cell nuclei
along the basement membrane as spermatogonia and prelep-
totene spermatocytes were absent (Figs. 1H, 3). Leptotene
and zygotene spermatocytes also were absent from some dis-
rupted tubules and numerous vacuoles were found in loca-
tions in which premeiotic and meiotic germ cells were
missing. Pachytene spermatocytes as well as round and elon-
gated spermatids were present 29 days after tamoxifen
treatment.
At 43 days after knockout, all germ cells were absent
except for elongated spermatids (Fig. 1I). The elongated
spermatids were distributed randomly with many having
their acrosomes misoriented away from the Sertoli cell
nuclei suggesting that the attachment of the elongated
spermatids to the supporting Sertoli cells was misregulated.
The mislocalization of elongated spermatids has been
shown to result in phagocytosis of the germ cells by Sertoli
cells [26]. At 63 days after tamoxifen treatment, tubules
with disrupted spermatogenesis lacked all germ cells and
contained only Sertoli cells (Fig. 1J). Ptpn11D/D male mice
retained normal mating behavior, but fertility was reduced
as matings of at least 6 weeks produced litters at a 50%
rate (5/10), whereas control mice treated with tamoxifen
produced litters at a rate of 82% (14/17). Fertility of the
Ptpn11D/D mice is likely maintained due to the presence of
tubules in which SHP2 expression was retained and sperma-
togenesis was not disrupted.
SHP2 Is Expressed in SSCs and Undifferentiated
Spermatogonia
Immunohistochemical studies of adult mouse testis sections
showed that SHP2 was expressed in Sertoli cell nuclei as well
as in Sertoli cytoplasm at the basement membrane, the BTB,
and between germ cells (Fig. 2A). SHP2 also was expressed in
spermatogonia on the basement membrane but expression
was low or undetectable in spermatocytes and spermatids
(Fig. 2A, Supporting Information Fig. S1). To determine
whether SHP2 is expressed in SSCs and undifferentiated sper-
matogonia in the testis, we assessed SHP2 coexpression with
the promyelocytic leukemia zinc ﬁnger (PLZF)-transcription
factor (Zbtb16), a marker for these cell types [27, 28]. In
testes sections from postnatal day 15 (P15) wild-type mice
that have a high proportion of undifferentiated spermatogo-
nia cells, we found that SHP2 was coexpressed in positive
cells and present in the Sertoli cell cytoplasm surrounding
germ cells (Fig. 2B). We also found that SHP2 was coex-
pressed with the more rare PLZF-positive cells in testis cross-
sections from adult wild-type mice (Fig. 2C). Further studies
were performed in primary cultures of mouse GS cells. These
cultures consist of SSCs as well as undifferentiated spermato-
gonia derived from SSCs that are supported by feeder cells [7,
29]. SHP2 was coexpressed with all PLZF-positive cells in the
GS cell culture indicating that SHP2 is expressed in SSCs and
undifferentiated spermatogonia (Fig. 2D). There also were
some SHP2-positive cells that did not express PLZF. This pat-
tern of SHP2 expression is consistent with the hypothesis that
SHP2 regulates SSC fate as well as the production of undiffer-
entiated spermatogonia.
SHP2 Is Required to Replenish Germ Cells
To identify the ﬁrst stages of germ cell development affected
by SHP2 knockout, testis cross-sections from Ptpn11D/D mice
were probed with antisera against SOHLH1 or PLZF. These
studies showed that PLZF- and SOHLH1-positive cells were not
detected in disrupted tubules 29 or 43 days after SHP2 knock-
out and no germ cells were detected at 63 days (Fig. 3). The
staining of GATA4-positive Sertoli cells did not change in the
disrupted tubules. The lack of SOHLH1- and PLZF-positive cells
detected in disrupted tubules after tamoxifen treatment sug-
gests that SSCs are depleted or unable to proliferate in the
absence of SHP2.
Examination of testis cross-sections from P15 Ptpn11D/D
mice that were treated with tamoxifen on P8 and P9 revealed
an increase in PLZF-positive cells lacking SHP2 due to the
ablation of SHP2 expression. These SHP2-deﬁcient/PLZF-posi-
tive cells were clustered in speciﬁc tubule cross-sections,
whereas PLZF-positive/SHP2 negative cells were less frequent
and more evenly distributed in cross-sections from control
mice (Supporting Information Fig. S2). These data are consist-
ent with the mosaic pattern of spermatogenesis disruption in
adult Ptpn11D/D mice originating in pups with SHP2 deﬁcient
SSCs and undifferentiated spermatogonia localized in speciﬁc
seminiferous tubules.
The Production of Germ Cell-Specific SHP2
Knockout Mice
Studies of the Ptpn11D/D mice indicated that SHP2 is required
to maintain the production of germ cells. However, the global
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knockout of SHP2 did not determine whether germ cell
replenishment and cell attachment defects in the absence of
SHP2 were due to SHP2 actions in SSCs or in Sertoli cells. To
identify the functions of SHP2 speciﬁc to germ cells, Ptpn11ﬂ/ﬂ
mice were mated with mice expressing Cre recombinase driven
by the Vasa (Ddx4) promoter, which causes Cre to be
expressed speciﬁcally in germ cells beginning on fetal day 15
[23]. Genotypic analysis of progeny identiﬁed germ cell-speciﬁc
SHP2 knockout (GCSHP2KO) mice having Ptpn11 genes with
exon 4 deleted (Ptpn11D/D) in germ cells (Fig. 4A). Immunoblot
analysis showed that SHP2 levels decreased in GCSHP2KO mice
4 and 8 weeks after birth (Fig. 4B).
The weights of GCSHP2KO testes 3, 4, and 8 weeks after
birth were reduced 56%, 46%, and 80%, respectively, in com-
parison to control littermates (Fig. 4C). Diameters of the semi-
niferous tubules from 3-, 4-, and 8-week-old GCSHP2 mice
were reduced by 24%, 39%, and 51%, respectively (Fig. 4D).
In contrast to the mosaic of disrupted tubules observed in
the Ptpn11D/D mice, low magniﬁcation analysis of testis sec-
tions from GCSHP2KO mice revealed a progressive loss of
germ cells in nearly all seminiferous tubules (Fig. 4E). By 8
weeks after birth, GCSHP2KO mice totally lacked germ cells in
all tubule cross-sections. These data indicate that SHP2
expression in germ cells is essential to maintain the germline.
Figure 2. SHP2 is expressed in spermatogonial stem cells and undifferentiated spermatogonia. (A): Adult wild-type mouse testis sec-
tions were probed with antiserum against SHP2 and stained with hematoxylin (blue). The SHP2 immunostaining (brown) was localized
to Sertoli (S) nuclei and Sertoli cell cytoplasm between germ cells (black arrowheads) and around ES as well as along the basement
membrane in a region consistent with the blood-testis barrier (red arrows) that did not extend beyond the apical side of spermatogonia
(Sp) or preleptotene spermatocytes (Pl). Bar5 20 mm. (B): P15 wild-type mice were probed with antisera against PLZF (top, red) or
SHP2 (bottom, green). Nuclei were stained blue with 4060-diamidino-2-phenylindole. Cells numbered 8–13, 16, and 18 were PLZF and
SHP2 positive. Bar5 100 mm. (C): Images of adult testis cross-sections are shown after probing with antisera against PLZF and SHP2 and
the merging of the signals. Arrows mark spermatogonia that express PLZF and SHP2. Bar5 20 mm. (D): Images of GS cells probed with
PLZF and SHP2 and the merged signals. Yellow arrows mark clusters of GS cells that coexpress PLZF and SHP2. Green arrows mark GS
cells that express only SHP2. Red arrows mark larger nuclei of feeder cells in the background that express SHP2. Bar5 20 mm. Abbrevia-
tion: ES, elongated spermatids.
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SHP2 Is Required for the Production of
Undifferentiated Spermatogonia
Immunohistochemistry studies performed on testes from
GCSHP2KO mice 3 weeks after birth revealed that sperma-
tocytes and spermatids were present, but Vasa-positive
cells were not detected on the basement membrane indi-
cating that spermatogonia and preleptotene spermatocytes
were absent (Fig. 5, top row). By 4 weeks after birth, germ
cells in the GCSHP2KO mice had progressed to become
round spermatids and elongated spermatids but less
mature germ cells from spermatogonia to pachytene sper-
matocytes were absent. By 8 weeks, no Vasa-positive germ
cells were present. Probing with SOHLH1 antisera (Fig. 5,
second row) or PLZF antisera (Fig. 5, third row) identiﬁed
differentiated and undifferentiated spermatogonia, respec-
tively, on the basement membrane of control mouse testis
but these cells were absent 3, 4, and 8 weeks after birth in
GCSHP2KO mice. The inability to replenish germ cells in
GCSHP2KO mice indicates SHP2 is essential for the survival
or proliferation of SSCs. In contrast, staining of Sertoli cells
with antiserum against GATA4 was similar in control and
GCSHP2KO testes at all developmental ages (Fig. 5, bottom
row).
The presence of spermatocytes and spermatids in
GCSHP2KO mice 3 and 4 weeks after birth demonstrates that
the elimination of SHP2 speciﬁcally from germ cells did not
interfere with the production of differentiated spermatogonia
from gonocytes in the ﬁrst wave of spermatogenesis. Also,
the progression of spermatogenesis after the differentiated
spermatogonia stage of development was not affected. These
results conﬁrm that knockout of SHP2 expression does not
inhibit the differentiation or proliferation of spermatogonia or
the developmental transition to spermatocytes.
SHP2 Is Required for the Proliferation and Survival of
SSCs
In testis sections from control mice 5 days after birth that
contain a high proportion of SSCs and undifferentiated sper-
matogonia, SHP2 and PLZF immunostaining were colocalized
in SSCs and undifferentiated spermatogonia plus SHP2 was
present in the Sertoli cell cytoplasm surrounding germ cells.
In GCSHP2KO mice, SHP2 immunostaining was retained in the
Sertoli cell cytoplasm but SHP2 colocalization with PLZF was
rare indicating that SHP2 expression was extinguished in
nearly all SSCs and undifferentiated spermatogonia (Support-
ing Information Fig. S3).
Figure 3. Undifferentiated and differentiated spermatogonia are not present after broad knockout of SHP2. Testis tissues from control
mice and Ptpn11D/D mice 29, 43, and 63 days after tamoxifen treatment were probed with antisera against PLZF, SOHLH1, and GATA4.
Representative immunopositive staining (brown) is noted with arrows. Bar5 20 mm.
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To determine whether SSCs and undifferentiated sperma-
togonia were absent in GCSHP2KO mice because the knockout
of SHP2 caused the loss of gonocyte precursor cells, testis sec-
tions from P2 GCSHP2KO mice were probed with antisera
against Vasa. These studies indicated that the distribution and
number of gonocytes were similar in control and GCSHP2KO
mice (Fig. 6A, 6D). Thus, the lack of SHP2 does not cause the
loss of germ cell precursors and SHP2 must be required at a
later stage in germ cell development.
Gonocytes reenter the cell cycle on P3 and give rise to
SSCs from P3.5 to P5 [1, 2]. We compared the numbers of
cells per tubule for SSCs and any undifferentiated spermato-
gonia that were present in control and GCSHP2KO mice at P5
by probing testis tissue sections with PLZF antiserum. As
expected, the proliferation of gonocytes, SSCs, and undifferen-
tiated spermatogonia in control mice increased the number of
PLZF-positive cells at P5 over that of the number of gonocytes
(Vasa-positive cells) at P2 (Fig. 6B, 6D). However, PLZF-positive
cells in GCSHP2KO mice were reduced to 44% of littermate
controls. In control mice, the number of PLZF-positive cells
per tubule was not altered signiﬁcantly from P5 to P7. How-
ever, PLZF immunostained cells in GCSHP2KO testes were fur-
ther reduced to 39% of control levels at P7 (Fig. 6C). These
results indicate there is a reduction in the number SSCs and/
or undifferentiated spermatogonia in the absence of SHP2. In
contrast, GATA4 staining of Sertoli cells was similar for control
and GCSHP2KO mice at each developmental time point (Fig.
6A–6C).
TUNEL assays revealed that apoptosis generally increased
in seminiferous tubules during the P2 to P7 developmental
Figure 4. Ablation of SHP2 expression in germ cells results in the loss of all germ cells. (A): PCR analysis of the region encompassing
exon 4 of Ptpn11 in testis tissue from WT, ﬂoxed Ptpn11 (ﬂoxed), and GCSHP2KO mice. Analysis of the presence of Cre in the VasaCre
transgene is shown below. (B): Western immunoblot analysis of whole testis extracts from control and GCSHP2KO (KO) mice probed
with antisera against SHP2 or b-actin. (C, D): Mean (6SEM) weights of pairs of testes (C) and seminiferous tubule diameters (D) from
3-, 4-, and 8-week-old control and KO mice are shown. Age matched pairs marked with asterisks (*) differ signiﬁcantly (p [lt] .05), For
(C) n5 2 except 8 week-old KO5 5. For (D) at least 10 cross-sections were measured for each condition. (E): Testis tissue from 3-, 4-,
and 8-week-old control and GCSHP2KO mice stained with PAS-H. Bar5 100 mm. Insets show the relative sizes of the testes isolated
from wild-type and GCSHP2KO mice. Abbreviations: KO, knockout; WT, wild type.
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time course, but the overall frequency of apoptosis was rela-
tively low ([lt] 0.6 TUNEL-positive cells/tubule) (Fig. 6E). At P5
and P7, the number of apoptotic cells per tubule for
GCSHP2KO and control mice were similar. However, because
the number of PLZF-positive cells in GCSHP2 mice was
reduced to 44% or 39% of controls, these results suggest that
the remaining cells undergo apoptosis more frequently than
control mice. This idea was conﬁrmed by further analysis
showing that the percentage of PLZF-positive cells in
GCSHP2KO mice that were also positive for the cleaved
caspase-3 marker of apoptosis was elevated by 2.5- and 2.7-
fold at P5 and P7, respectively (Fig. 6F, Supporting Informa-
tion Fig. S4A). As suggested by the TUNEL results, the fre-
quency of apoptotic PLZF-positive cells was low in GCSHP2KO
mice ([lt] 2%) and did not reconcile with the 56%–61%
decrease in PLZF-positive cells observed in GCSHP2KO mice. In
contrast, proliferation of PLZF-positive cells as assayed by Ki-
67 immunostaining was reduced by 52% in GCSHP2 mice at
P5. Two days later (P7) the number of proliferating PLZF-
positive cells in control mice was 35% lower, but in
GCSHP2KO mice there was a further 33% decrease in PLZF-
positive cells compared to control littermates (Fig. 6G, Sup-
porting Information Fig. S4B). Together, these data suggest
that the decrease in PLZF-positive cells in GCSHP2KO mice is
predominately due to the failure of SSCs to proliferate,
although apoptosis may contribute to the elimination of SSCs
and undifferentiated spermatogonia (Fig. 6H).
SHP2 Supports the Attachment of SSCs to Supporting
Cells, SSC Proliferation, and Growth Factor Signaling in
Culture
Further studies were performed to determine whether SHP2
mediated the intracellular signals originating from bFGF and
GDNF growth factors that are required to maintain the
Figure 5. Undifferentiated and differentiated spermatogonia are not produced by GCSHP2 mice. Testis tissue sections from 3-week-old
control and 3-, 4-, and 8-week old GCSHP2KO mice were probed with antisera against Vasa, SOHLH1, PLZF, and GATA4. For Vasa staining,
arrows mark the presence of stained spermatogonia on the basement membrane (control testes only) and more mature germ cells in
the adluminal compartment in control and GCSHP2 testes. For SOLHLH1 and PLZF staining, arrows mark differentiated and undifferenti-
ated spermatogonia, respectively, present only in control testes. For GATA4 staining, arrows mark Sertoli cell nuclei in all conditions.
Bar5 20 mm.
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Figure 6. The number of SSCs and undifferentiated spermatogonia are decreased 5 and 7 days after birth in GCSHP2KO mice. (A): Tes-
tis tissue sections from P2 control and GCSHP2KO mice were probed with antisera against Vasa or GATA4. Bar5 20 mm. (B, C): Testis
sections from P5 and P7 control and GCSHP2KO mice were probed with PLZF or GATA4 antisera. Bar5 20 mm. (D): Quantitation of
Vasa-positive (P2, n5 2) and PLZF-positive (P5, n5 4 and P7, n5 2) cells per tubule for control and GCSHP2KO testis sections. (E):
Quantitation of TUNEL-positive cells per tubule for P2 (n5 2), P5 (n5 2), and P7 (n5 3) control and GCSHP2KO testis sections. (F): Tes-
tis sections from P5 and P7 control and GCSHP2KO mice were probed with antisera against PLZF and the apoptosis marker cleaved
caspase-3. The percentage of PLZF-positive cells that also express cleaved caspase-3 was quantiﬁed from entire tissue sections (259–
1,453 PLZF-positive cells/section, n5 3). (G): Testis sections from P5 and P7 control and GCSHP2KO mice were probed with antisera
against PLZF and the proliferation marker Ki-67. The percentage of PLZF-positive cells that also express Ki-67 was quantiﬁed as in panel
G from 386 to 1,107 PLZF-positive cells/section. Statistical analysis of P5 control versus P5 GCSHP2KO as well as P7 control versus P7
GCSHP2KO comparisons in panels (F) and (G) was evaluated by unpaired t test. Asterisks denote pairs in which the means are statisti-
cally signiﬁcant (n5 3). (H): Schematic summary of spermatogenesis including gonocytes producing differentiated A2 spermatogonia in
the ﬁrst wave. After conversion of gonocytes to SSCs, successive waves of spermatogenesis require SSC proliferation for self-renewal
and production of A aligned (Aal) undifferentiated spermatogonia that transition into A1 differentiated spermatogonia and eventually to
sperm. Values with different lower case letters differ signiﬁcantly (p [lt] .05). Abbreviation: SSC, spermatogonial stem cell.
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survival, and proliferation of SSCs in GS cell cultures and in
vivo [5, 7, 30–32]. We focused on SHP2 regulation of ERK
kinase that supports the proliferation and renewal of SSCs
[33, 34]. GS cell cultures were isolated from their feeder cells
and treated with bFGF or GDNF for 10 minutes in the absence
and presence of the SHP2 selective inhibitor NSC-87877. Addi-
tion of bFGF or GDNF increased the phosphorylation (activa-
tion) of ERK as expected (Fig. 7A), but pretreatment with
NSC-87877 inhibited the bFGF and GDNF-mediated phospho-
rylation of ERK. These data suggest that SHP2 activity is
required to transmit signals within SSCs that are essential for
proliferation and survival. Addition of NSC-87877 to the GS
cell cultures for 5 days resulted in a threefold increase in the
number of GS cells detached from feeder cells (Fig. 7B) sug-
gesting that SHP2 may be required for GS cells to attach to
their niche.
A 5-day treatment with NSC-87877 caused the number of
GS cells to be reduced by 22% (Fig. 7C). Cell death in the GS
cultures was similarly low in the absence and presence of
NSC-87877 (Fig. 7D). The magnitude of the NSC-87877-
mediated decrease in GS cells is consistent with the inability
of the less abundant SSCs to proliferate. However, we cannot
rule out the possibility that NSC-87877 speciﬁcally mediated
the death of SSCs that make up a small portion of the GS cell
population. Injection (ip) of NSC-87877 (10 mg/kg) into adult
mice daily for 7 days followed by analysis 15 days later
revealed that NSC-87877 caused disruption of spermatogene-
sis similar to that observed for Ptpn11D/D mice including the
absence of spermatogonia and most mature germ cells except
for a few mislocalized elongated spermatids (Fig. 7E). The
germ cells that were present were detached from supporting
Sertoli cells and localized to the tubule lumen. These results
provide further evidence that SHP2 activity is required for
SSCs to replenish germ cells.
DISCUSSION
Using mouse models in which SHP2 expression is eliminated
in all cells or only in germ cells, we found that SHP2 is essen-
tial to complete the initial step of spermatogenesis, the pro-
duction of undifferentiated spermatogonia from SSCs. In the
absence of SHP2, undifferentiated spermatogonia are not
present but germ cells beyond this stage of development are
capable of completing the process of spermatogenesis.
The inability to produce undifferentiated spermatogonia is
not due to the death of gonocyte precursors of SSCs because
the elimination of SHP2 speciﬁcally in germ cells did not alter
the number of gonocytes present 2 days after birth. We can-
not rule out the possibility that SHP2 contributes to the tran-
sition of gonocytes into SSCs between P2 and P5. However,
ablation of SHP2 in adult Ptpn11D/D mice prevents the replen-
ishment of undifferentiated spermatogonia well after all gono-
cytes have been converted to A2 spermatogonia or SSCs
indicating that the lack of undifferentiated spermatogonia
must be due to a defect in SSCs.
In the GCSHP2KO mouse, production of undifferentiated
spermatogonia from SSCs was inhibited as evidenced by the
56% and 61% decrease in PLZF-positive cells on P5 and P7,
respectively, and the absence of all spermatogonia production
prior to 3 weeks after birth. This decrease in the SSC and
undifferentiated spermatogonia population coincided with a
55% and 33% decrease in proliferating PLZF-positive cells in
GCSHP2KO mice at P5 and P7. These data support the hypoth-
esis that germ cells cannot be replenished and self-renewal of
SSCs cannot occur due to a block in the proliferation of SSCs
in the absence of SHP2. Similar effects have been described
in SHP2-deﬁcient neuronal stem cells [35]. Apoptosis may
contribute to the decrease in SSCs and undifferentiated sper-
matogonia as the frequency of apoptosis increases by two- to
Figure 7. Inhibition of SHP2 blocks GDNF and bFGF signaling,
causes spermatogonial stem cells (SSCs) to detach from their
niche, decreases the number of SSCs in culture, and disrupts
spermatogenesis. (A): Germ line stem (GS) cultures were stimu-
lated for 10 minutes with bFGF (20 ng/ml) or GDNF (20 ng/ml)
with or without 5 hours pretreatment with NSC-87877 (NSC, 50
mM). Immunoblot analysis of p-ERK and ERK levels after the treat-
ments is shown. Data shown is representative of two (GDNF) and
three (FGF) replicate cultures (B) GS cultures were treated for 5
days with vehicle or NSC-87877 (50 mM). The percentage of cells
detached from feeder cells was determined (n5 3; *, p [lt] .05).
(C): GS cells treated with vehicle or NSC (50 mM) as in (B) were
isolated from feeder cells, dispersed, and counted (n5 3; *, p [lt]
.05). (D): Clumps of GS cells (white arrows) and feeder cells (yel-
low arrows) treated as in (D) were assayed for live (green) and
dead (red) cells. Magniﬁcation is 320. (E): Testis sections from
wild-type mice isolated 15 days after injection with vehicle, or
NSC-87877 (10 mg/kg) for 7 days were stained with PAS-H. Green
arrows: spermatogonia; black arrows: Sertoli cell nuclei; Orange
arrows: mislocalized elongated spermatids; Blue arrow: a cluster
of prematurely detached germ cells. Abbreviations: FGF, ﬁbroblast
growth factor; GDNF, glial cell-derived neurotrophic factor; NSC,
NSC-87877.
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threefold in GCSHP2KO mice. It is possible that the increase
in apoptosis may reﬂect a clearing of SSCs and undifferenti-
ated spermatogonia in response to their inability to prolifer-
ate. However, the overall low percentage of PLZF-positive cells
undergoing apoptosis would not appear to be a major deter-
minant of the loss of PLZF-positive cells.
The relatively small but signiﬁcant reduction (22%) in the
number of GS cells in culture after 5 days of treatment with
the SHP2 inhibitor NSC-87877 is consistent with blocking the
proliferation of the more rare SSCs ([lt]10% of the heteroge-
neous culture [36]) that are needed to produce undifferenti-
ated spermatogonia. The smaller magnitude of decrease for
cultured GS cells compared to PLZF-positive cells in vivo after
the loss of SHP2 activity also is consistent with the slower
proliferation of GS cells (5.6-day doubling time) [7] versus
that of undifferentiated spermatogonia in vivo (30–70 hours)
[37, 38]. The absence of spermatogonia 15 days after injection
of mice with NSC-87877 further supports the hypothesis that
SHP2 is required for SSCs to replenish germ cells. Inhibition of
SHP2 produced a dramatic disruption of spermatogenesis sim-
ilar to that observed after knockout of SHP2 in all cells in the
Ptpn11D/D mice including the detachment of meiotic and
postmeiotic germ cells as well as mislocalization of elongated
spermatids. These data suggest that in addition to maintaining
SSCs, SHP2 performs functions in Sertoli cells (and perhaps
other cells) required for germ cell attachment and the support
of spermatogenesis. The NSC-87877-mediated elimination of
SSCs and differentiated germ cells also suggests inhibitors of
SHP2 or SHP2 targets, if delivered speciﬁcally to the testis,
could be used to permanently sterilize animals as a mecha-
nism to humanely solve challenges of animal overpopulation.
NSC-87877-mediated inhibition of SHP2 caused a threefold
increase in the number of GS cells that were detached from
their feeder cells. This result raises the possibility that SHP2 is
required to maintain SSCs in their niche and that release from
the niche may contribute to decreased survivability of SSCs or
remove the SSCs from the signals required to produce undif-
ferentiated spermatogonia. It is not known yet whether SSC
detachment is caused by the inhibition of SHP2 in SSCs or
their supporting cells.
Ptpn11D/D mice and mice lacking the SHP2-regulated ETV5
gene are similar in that both display misorientation of elon-
gated spermatids [39] suggesting that SHP2 is part of a signal-
ing pathway required to regulate germ cell attachment. The
localization of SHP2 immunoreactivity in Sertoli cells to
regions surrounding elongating spermatids is consistent with
our observations that SHP2 is a regulator of Sertoli-germ cell
adhesion. Previously, we found that constitutive activation of
SHP2 disrupts Sertoli-Sertoli cell junctional complexes by mis-
localization of adherens junction proteins b-catenin and N-
cadherin and disruption of the actin cytoskeleton [19].
In the GCSHP2KO mice 3 and 4 weeks after birth, pachy-
tene spermatocytes and spermatids were present indicating
that the ﬁrst wave of spermatogenesis occurs after knockout
of SHP2. The production of the ﬁrst wave provides further evi-
dence that gonocytes in GCSHP2KO mice are able to produce
differentiated spermatids 3–5 days after birth and conﬁrms
that the lack of SHP2 expression only affects the survival of
germ cells prior to the differentiated spermatogonia stage of
development. The transient presence of pachytene spermato-
cytes and spermatids in Ptpn11D/D mice also showed that
germ cells that were beyond the undifferentiated spermatogo-
nia stage of development at the time of SHP2 knockout were
able to continue their maturation in a “ﬁnal wave” of
spermatogenesis.
The necessity for SHP2 to replenish germ cells from SSCs
is reminiscent of SHP2 functions in other stem cells. Deletion
of the SHP2 gene in hematopoietic stem cells disrupts their
quiescent state, and self-renewal while increasing apoptosis
resulting in a severe reduction in mature blood cells [40, 41].
Similarly, the survival of trophoblast stem cells is dependent
upon SHP2 [42]; whereas SHP2 deletion in neuronal stem cells
impairs their proliferation and differentiation resulting in
lethality [35].
The progressive loss of germ cells and the resulting Sertoli
cell only phenotype that was found after elimination of SHP2
expression has been reported in mice engineered to lack
expression of SSC markers such as PLZF, ETV5, FOXO1, and
Sin3a [39, 43–45]. Mice lacking a single allele of GDNF show a
similar phenotype [5] and GDNF is known to activate SHP2 in
other cells [8, 46]. bFGF that acts in concert with GDNF to
maintain the pool of SSCs also mediates its signaling through
SHP2 in a variety of cell types [9, 34, 47]. Additionally, the
ETV5 and FOXO1 transcription factors that are required to
maintain the SSC pool are downstream targets of SHP2 [11,
44, 46]. The more dramatic phenotype of the SHP2 deﬁcient
mouse models may be due to SHP2 being a mediator of both
GDNF and bFGF signaling as well as a regulator of ETV5 and
FOXO1 required for SSC self-renewal and/or survival. Thus, it
is possible that SHP2 is a central nexus and rheostat for intra-
cellular signaling pathways in SSCs that are essential for the
ﬁne-tuning of signals required for the production of undiffer-
entiated spermatogonia. Supporting this hypothesis is our
ﬁnding that inhibition of SHP2 activity by NSC-87877 in cul-
tured GS cells decreased bFGF- and GDNF-mediated activation
of ERK. In addition, recent analysis of mutation frequencies in
sperm from Noonnan syndrome patients suggests that SHP2
gain of function mutations in SSCs provides a competitive
advantage for the production of sperm [48]. Further studies
will be required to determine whether SSC fate is determined
by SHP2 regulation of ETV5, FOXO1, or other targets in
response to GDNF and bFGF signaling.
CONCLUSION
The expression of SHP2 is critical for maintaining the male
germline and fertility. SHP2 mediates GDNF and FGF signals
needed for the maintenance of SSCs and the production of
undifferentiated spermatogonia. In the absence of SHP2, SSCs
are not able to proliferate and germ cells cannot be replen-
ished. Our ﬁndings may be applied to develop therapies for
SHP2 defects that result in infertility. Speciﬁcally, Noonan and
LEOPARD patients having mutations that misregulate SHP2
expression would be expected to have compromised SSC and
Sertoli cell function leading to disruption of spermatogenesis.
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